ZimVie Inc. $ZIMV Stock Position Raised by Gamco Investors INC. ET AL

Key Points

• Gamco Investors INC. ET AL increased its stake in ZimVie Inc. by 22.6% during the first quarter, now owning 636,341 shares valued at approximately $6.87 million.
• AlphaQuest LLC significantly boosted its holdings in ZimVie by 2,695.9%, while total institutional ownership in the company stands at 95.63%.
• ZimVie reported a quarterly EPS of $0.26, exceeding analyst expectations of $0.21, and had a revenue of $116.66 million compared to the expected $112.60 million.

Gamco Investors INC. ET AL lifted its holdings in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 22.6% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 636,341 shares of the company's stock after purchasing an additional 117,229 shares during the quarter. Gamco Investors INC. ET AL owned 2.29% of ZimVie worth $6,872,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently modified their holdings of the company. American Century Companies Inc. grew its stake in shares of ZimVie by 10.0% in the first quarter. American Century Companies Inc. now owns 690,675 shares of the company's stock worth $7,459,000 after purchasing an additional 62,625 shares in the last quarter. BNP Paribas Financial Markets bought a new position in shares of ZimVie in the fourth quarter worth $416,000. Russell Investments Group Ltd. grew its stake in shares of ZimVie by 10.5% in the first quarter. Russell Investments Group Ltd. now owns 305,431 shares of the company's stock worth $3,299,000 after purchasing an additional 28,988 shares in the last quarter. Forest Hill Capital LLC grew its stake in shares of ZimVie by 25.9% in the fourth quarter. Forest Hill Capital LLC now owns 172,809 shares of the company's stock worth $2,411,000 after purchasing an additional 35,500 shares in the last quarter. Finally, Wealthquest Corp bought a new position in shares of ZimVie in the first quarter worth $182,000. Institutional investors own 95.63% of the company's stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on ZIMV shares. UBS Group decreased their price target on ZimVie from $16.00 to $10.00 and set a "neutral" rating for the company in a research note on Thursday, May 15th. Wall Street Zen cut ZimVie from a "strong-buy" rating to a "buy" rating in a research note on Friday, July 18th. B. Riley cut ZimVie from a "buy" rating to a "neutral" rating and set a $19.00 target price for the company. in a research note on Thursday, July 31st. Finally, Barclays raised ZimVie from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $9.00 to $19.00 in a research note on Tuesday, July 22nd. Four investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $17.75.

ZimVie Trading Down 0.1%

NASDAQ ZIMV traded down $0.02 on Monday, hitting $18.88. 300,975 shares of the company were exchanged, compared to its average volume of 332,097. The company's 50 day moving average price is $15.01 and its 200-day moving average price is $11.94. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.37 and a quick ratio of 1.60. The firm has a market capitalization of $532.42 million, a P/E ratio of -26.97 and a beta of 2.20. ZimVie Inc. has a twelve month low of $8.15 and a twelve month high of $19.00.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.21 by $0.05. The firm had revenue of $116.66 million for the quarter, compared to the consensus estimate of $112.60 million. ZimVie had a positive return on equity of 6.37% and a negative net margin of 4.39%. Analysts predict that ZimVie Inc. will post 0.6 earnings per share for the current fiscal year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.